Home › Encyclopedia › Taltirelin: Research Status and Clinical Trial Data
Research / Unapproved

Taltirelin: Research Status and Clinical Trial Data

Molecular formulaC17H23N7O5
Molecular weight405.4 g/mol
Registered trials1
PubChem CID114750

What Taltirelin Is

Taltirelin is a synthetic compound with the molecular formula C17H23N7O5 and a molecular weight of about 405.4 g/mol (PubChem CID 114750). It does not have an approved drug label in this dataset, meaning there is no FDA-sanctioned indication, dosing standard, or verified safety profile on file here. Any use of taltirelin outside of registered clinical research falls outside the scope of this information.

Trial Footprint

One registered trial record is available for taltirelin. That study, "C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration" (NCT04107740), has a completed status. This dataset does not support conclusions about safety or effectiveness, and no efficacy or outcome claims can be drawn from a single trial record.

FAQ

Is taltirelin FDA approved?
No. This dataset shows no approved drug label for taltirelin, so there is no FDA-sanctioned indication or official use. Any application remains in the research or investigational space.
What is taltirelin's chemical identity?
Taltirelin has the molecular formula C17H23N7O5 and a molecular weight of approximately 405.4 g/mol. It is cataloged under PubChem CID 114750.
How many clinical trials involve taltirelin?
The available data lists one registered clinical trial for taltirelin. That trial, focused on orally disintegrating tablets in ataxia due to spinocerebellar degeneration, has a completed status.
Does this information include side effect data for taltirelin?
No. No adverse event report data is available in this dataset for taltirelin, so side effects cannot be summarized here.
Can taltirelin be used for ataxia treatment based on this data?
This dataset does not support that conclusion. A single completed trial record does not establish safety or effectiveness, and taltirelin carries no approved label in this dataset.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 114750 ClinicalTrials.gov NCT04107740

Updated 2026-11-07